The major capsid protein (MCP) of human cytomegalovirus (HCMV) was expressed in three portions as fl-galactosidase fusion proteins, covering about 75 % of the open reading frame (ORF). Fusion protein SH 1 contained nucleotides 101 to 1243 of the ORF, fusion protein FS 1 contained nucleotides 1944 to 3089 and fusion protein SS 1 covered nucleotides 2624 to 3793. The recombinant proteins were tested for their immunoreactivity with human sera. Fusion protein FS 1 was found to represent the immunodominant region. The recombinant proteins were used to generate polyvalent rabbit antisera to investigate cross-reactivities with the major capsid protein (VP5) of herpes simplex virus type 1 (HSV-1). A monospecific antiserum raised against the fusion protein close to the N terminus of the MCP, as well as a monoclonal antibody and a monospecific rabbit antiserum directed against the viral MCP, cross-reacted with the VP5 as shown by immunoblotting and immunofluorescence. In order to detect common epitopes of the major capsid proteins of HCMV and HSV-1, the recombinant proteins were conjugated to CNBr-activated Sepharose and taken for purification of MCP antibodies from HCMV and HSV-1 seropositive individuals. Using this affinity chromatography method, cross-reactivity could be observed with HCMV-and HSV-positive human antisera in immunoblot experiments.
Introduction
Human cytomegalovirus (HCMV) and herpes simplex virus type 1 (HSV-1), two members of the herpesvirus family, are the source of a variety of human diseases, arising from primary infection or from reactivation of latent virus. More than 50 virus-specified proteins can be identified in cells infected with herpesviruses (Roizman & Batterson, 1985) and a minimum of 25 proteins are structural components. Studies on immunogenic viral proteins have been done by immunoprecipitation and immunoblotting (Pereira et al., 1982; Landini et al., 1985; Eberle & Mou, 1983; Eberle et al., 1985; Kfihn et al., 1987) . For HSV-1 a prominent antibody response can be observed against viral glycosylated envelope proteins such as glycoprotein B (Bernstein et al., 1985; Kahlon et al., 1986) . In addition, the major capsid protein (VP5) of HSV-1 serves as a dominant antigen (Eberle & Mou, 1983) , whereas the major capsid protein (MCP) of HCMV appears to be of limited antigenicity in its natural host (Jahn et al., 1987a) . For HCMV, the phosphorylated matrix protein of 150K (pp150), which has a similar electrophoretic mobility to that of the MCP, has proved to be highly reactive with human antisera (Jahn et al., 1987a, b; Scholl et al., 1988) . The sequence of ppl50 does not show any significant homology to open reading frames (ORFs) of other members of the herpesvirus group. The major capsid proteins of HSV-1 and HCMV have an amino acid identity of 25~. The nucleotides of the ORFs code for translation products having Mr values of 149K and 154K, respectively (Davison & Scott, 1986; Chee et al., 1989) . Apart from extensive cross-reactions between HSV-1 and HSV-2 viral proteins (Killington et al., 1977; Eberle & Courtney, 1981; Snowden & Halliburton 1985) , cross-reactivity has been reported for the closely related alphaherpesviruses HSV and varicella-zoster virus (VZV; Shiraki et at., 1982; Edson et al., 1985) . Further antigenic conservation was identified between Epstein-Barr virus (EBV) and HSV-encoded proteins by Littler et al. (1988) . Despite amino acid sequence conservation and preliminary epitope mapping, no immunological cross-reactivity has been described between the major capsid proteins of human herpesvirus subfamilies (Balachandran et al., 1987; Littler et al., 1988; Middeldorp & Meloen, 1988) 
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The MCPs of HSV, EBV and VZV play an important role in recognition by antibodies in human sera (Eberle & Mou, 1983; Vroman et al., 1985; Wolfet al., 1987; Dubey et al., 1988) . We chose the major capsid proteins of HCMV and HSV-1 in order to investigate crossreactivity and the conservation of different antigens that might be important in terms of the clinical and biological properties of these particular herpesviruses. For this purpose we expressed hybrid polypeptides consisting of defined stretches of the HCMV MCP in a high-level expression system and tested the recombinant proteins for their antigenic potential. Additionally, we used the fusion proteins for generating monospecific antisera in rabbits and for the purification of specific human antibodies to the MCP of HCMV. The monospecific rabbit antisera and the purified individual human sera were tested for cross-reactivities with the VP5 of HSV-1.
Methods
Viruses and cell culture. HCMV AD 169 was provided by U. Krech, St Gatlen, Switzerland. For the propagation of viruses, human foreskin fibroblasts (HFF) were used following standard procedures. Virion particles were purified from the supernatant of infected cells 96 h postinfection (p.i.) by centrifugal separation in glycerol tartrate gradients (Irmiere & Gibson, 1983) . The HSV-1 strain Angelotti (ANG ; Munk & Ludwig, 1972) was used for the preparation of virus stocks. Purified virions were obtained from infected RC-37 (African green monkey kidney) cells 36 h p.i. by centrifugal separation in sucrose gradients as described previously (Spear & Roizman, 1972) .
14C-labelled viral proteins were prepared by adding 6 ktCi/ml 14C-labelled amino acids (Amersham) in Basal Medium Eagle (BME) containing only 10 ~ of the standard amino acid concentration and 5 foetal calf serum (FCS), followed by a chase for several hours with normal BME supplemented with 5% FCS.
Wild-type HSV-I isolates were obtained from our diagnostic laboratory.
Vector systems and expression offusion proteins. The ORF of the MCP was cloned in pieces into the high-level expression vectors pBD2 IC2OH (Br6ker, 1986) or pROS (Ellinger et al., 1989) and transformed into Escherichia coli strain BMH 7118 (Messing et al., 1977) or E. coli strain D29A 1 (kindly provided by M, Br6ker, Behringwerke, Marburg, F.R.G.). One ml of overnight culture was diluted in 5 ml of LuriaBertani medium. Bacteria were grown at 37 °C to an optical density of 1.0 at 600 nm. Synthesis of fusion proteins was induced by adding IPTG to a final concentration of 1 raM. After 3 to 5 h, cells were collected by centrifugation.
Antisera and antibodies. Human sera were obtained from our diagnostic laboratory. All sera were routinely tested for the presence of antibodies against HSV and HCMV by ELISA (Behringwerke) and the complement fixation test (CFT) (Behringwerke). To avoid non-specific reactions with the bacterial part of the fusion proteins, each serum was incubated with the lysate of a 30 ml E. coli culture containing the expression vector without insert.
Antisera to the viral MCP and to HCMV fusion proteins were raised in New Zealand white rabbits. The viral MCP of HCMV was purified according to Jahn et al. (1987a) . For the preparation of the recombinant antigens, lysates of E. coli strain BMH 7118 harbouring the recombinant fl-galactosidase-MCP (fl-gal-MCP) proteins were treated with increasing concentrations of urea up to 7 M as described by Chee et al. (1989) . The fusion proteins accumulating in the supernatant of the last fraction were dialysed and taken for immunization as previously published (Jahn et al., 1987a) , The monoclonal antibody 28-4 directed against the MCP of HCMV was kindly provided by W. Britt, Birmingham, Alabama, U.S.A.
Purification of human antisera by affinity chromatography. Fusion proteins (4 rag) were conjugated to 1 g of CNBr-activated Sepharose 4B (Pharmacia). A column of the conjugated material was poured, washed and loaded with 0.5 ml serum as previously described by Gonyea (1977) . After all unbound serum had been washed off with phosphatebuffered saline (PBS), specific human antibodies to the corresponding recombinant protein were eluted with 0.1 M-glycine, 0.1 M-NaCI, pH 2.8. The column effluent was immediately adjusted to pH 7.5 with 2 raTris-HCl pH 10 and dialysed against PBS.
Protein gel electrophoresis and immunoblotting. Proteins were fractionated by SDS-PAGE essentially as described previously (Laemmli, 1970) . Resolving gels contained either 8-5% or 10% polyacrylamide. For the resolution of purified HCMV virions 'high-bis' polyacrylamide gels were used in order to separate the MCP at 154K and the basic phosphoprotein (ppl50) at 150K. Gels were stained with Coomassie blue or with silver nitrate (Merril et aL, 1981) . For Western blot analyses, proteins were electrophoretically transferred to nitrocellulose filters (Towbin et al., 1979) and blocked with PBS containing 2% bovine serum albumin and 0.05 % Nonidet P-40. After reaction with the antibody (diluted from 1:50 to 1:200), sheets were incubated with biotinylated anti-immunoglobulin G and horseradish peroxidasestreptavidin (Amersham). Antigens were detected by using 4-chloro-lnaphthol or diaminobenzidine in combination with COC12 and Ni(NH3)6SO4 (Sigma).
Immunofluorescence. For indirect immunoftuorescence, HFF cells were grown on glass coverslips and were methanol-fixed 72 h after infection with HCMV strain AD169. Vero cells were grown in cell culture flasks and were infected with recent clinical HSV-1 isolates. Ceils were harvested by trypsination at different times after infection, spotted on glass coverslips and fixed with methanol. HCMV-and HSV-1-infected cells were incubated with monoclonal antibody 28-4 for 30 min at 37 °C. Following extensive washing in PBS, bound antibody was detected with fluorescein-conjugated rabbit antimouse immunoglobulin (1:40 dilution; Dako Diagnostica). A commercial anti-HSV-1 monoclonal antibody (R6hm Pharma) was used as a control.
Results

Cloning and expression of the HCMV MCP
The gene sequence coding for the MCP of HCMV has been determined recently (Chee et al., 1989) . The ORF of 4110 bp spans the junction region of HindIII fragments a and U in the prototype arrangement of the HCMV AD169 genome (Fig. 1 ). Three portions of the ORF covering about 75% of the MCP sequence were cloned into the E. eoli expression vectors pBD2 IC2OH and pROS, respectively. The vectors contain the DNA sequence for a truncated N-terminal portion of fl-gal of 375 amino acids adjacent to a polylinker region which facilitates the in-frame ligation of gene fragments to flgalactosidase. A 1143 bp StuI/HindIII DNA fragment of the MCP (nucleotides 101 to 1243 of the ORF according to the published sequence; Chee et al., 1989) terminal sequence of the insert of pSS 1 overlaps with 466 bp of the carboxy-terminal part of pFS 1 (Fig. 1) . The recombinant clones were transformed into E. coli B M H 7118 and E. coli D29A 1 respectively. Bacteria directed highly efficient expression of the fusion proteins upon induction of the lac promoter by I P T G . The recombinant clones expressed hybrid proteins of the expected sizes of about 92K (pSH 1) and 95K (pFS 1 and pSS 1) as shown in Fig. 2 . The fusion proteins were used to generate antisera in New Zealand white rabbits. After the primary immunization and one booster injection, high-titred monospecific antisera were obtained that recognized the viral M C P in immunoblots.
Immunoreactivity of the recombinant proteins
The recombinant fl-gal-MCP proteins were used to investigate immunoreactivity with h u m a n H C M Vpositive antisera in immunoblotting. Sera of 37 H C M Vpositive individuals (as identified by E L I S A and CFT) were tested for antibody reactivity with the viral M C P and for their ability to recognize the various fusion proteins. It turned out that only 11 antisera reacted with the viral H C M V M C P in immunoblots. Apart from one exception, all antisera reactive with the viral M C P detected the hybrid protein FS 1. The antiserum which did not recognize fusion protein FS 1 showed an intense signal with the recombinant protein SH 1. 
Reactivity of the monospecific antisera and a monoclonal MCP antibody with the VP5 of HSV-1 in immunoblots
To investigate immunoreactivities of the HCMV polyvalent antisera with the VP5 of HSV-1, we separated HSV-1 ANG virions in denaturing protein gels containing 8.5~ polyacrylamide. Proteins were electrophoretically transferred to nitrocellulose and incubated with the monospecific antisera. Additionally, a monoclonal antibody (28-4) directed against the MCP of HCMV was applied for the investigation of cross-reactivities with the VP5. A strong antibody reactivity with the VP5 was observed in immunoblots using a polyvalent rabbit antiserum (Fig. 3, lane 6 ) and monoclonal antibody 28-4 (Fig. 3 , lane 4) directed against fusion protein SH 1 (Chee et al., 1989) . A polyvalent rabbit antiserum raised against the viral MCP of HCMV (Jahn et al., 1987a) reacted with fusion protein FS 1 and showed a cross-reaction with VP5 (data not shown). In contrast, the monospecific antisera raised against the recombinant proteins FS 1 and SS 1 did not reveal specific cross-reactions with VP5. Both antisera reacted with a number of additional HSV-1 proteins (data not shown).
Reactivity of the monospecific antisera and the monoclonal antibody in immunofluorescence
In a subsequent set of experiments we wanted to determine the intracellular localization of the MCP of HCMV. As the MCP represents a late gene product, HFF cells were infected with HCMV AD169 and fixed with methanol 72 h p.i. Incubation with monoclonal antibody 28-4 revealed a prominent nuclear fluorescence (Fig. 4a) . Similar results could be obtained using the polyvalent antisera directed against the recombinant proteins SH 1, FS 1 or SS 1. The rabbit antibodies showed a non-specific reaction most probably due to an interaction with the HCMV-induced IgG Fc receptor (Mackowiak & Marling-Cason, 1987) . The monoclonal antibody 28-4 was tested for its reactivity with HSV-1 in immunofluorescence. For this purpose, Vero cells were infected with five independent 
(a) Reactivity of human antisera after purification by affinity chromatography
The 11 HCMV-positive human antisera reactive with the viral MCP were screened for HSV antibodies by CFT, ELISA and immunoblotting. Eight of these antisera were subjected to affinity chromatography separation according to an HSV-positive IgG ELISA and the detection of the HSV-1 VP5 in immunoblots.
The individual data are summarized in Table 1 . Thus, CNBr-activated Sepharose columns were coated with fusion proteins FS 1 or SH 1 and loaded with the corresponding human antisera. After non-specifically adsorbed material had been washed off, specific antibodies to the recombinant HCMV proteins were subsequently eluted and tested for reactivity to the MCP of HCMV. All antibody effluents were found to be monospecific for the HCMV MCP whereas other viral proteins were not detected (example immunoblots are given in Fig. 5 ). To investigate whether the human antibodies purified by affinity chromatography crossreacted between HSV and HCMV, structural proteins of HSV-I (stra.in ANG) were incubated with the column effluents in immunoblots. As shown in Fig. 5 , three out of seven antisera purified on FS 1 affinity chromatography columns reacted with the VP5 of HSV-1. The single antiserum separated on an SH 1 affinity column did not recognize VP5 in immunoblots. Fig. 4 . Indirect immunofluorescence of (a) HFF 72 h after infection with HCMV ADI69 using the monoclonal MCP antibody 28-4 and of (b) HSV-1 infected Vero cells using monoclonal antibody 28-4 directed against the MCP of HCMV (i) and a commercial monoclonal antibody type-specific for HSV-1 (ii).
clinical HSV-1 isolates. After incubation with monoclonal antibody 28-4 all isolates investigated revealed HSV-l-positive immunofluorescences, as shown for one isolate in Fig. 4(b) . A commercially available anti-HSV-1 monoclonal antibody (R6hm) was applied as a positive control (Fig. 4b) . To exclude the possibility of nonspecific interactions of cells and antibodies, uninfected cells were incubated with monoclonal antibody 28-4 as a negative control.
Discussion
Human herpesviruses differ from each other in characteristics, such as DNA structure, cell tropism and rapidity of growth in vitro, forming the basis of their classification into three subfamilies. However, they also show common biological features in their morphology, DNA replication and virus assembly (Roizman & Batterson, 1985) . Thus herpesviruses possess both unique proteins for different characteristics and common structural or regulatory proteins for equivalent functions. For a number of genes, sequence conservation between the different herpesviruses has been determined at the nucleic acid and at the amino acid sequence level. The degree of homology between the major capsid proteins of HCMV and EBV is 29~, whereas that between the HCMV and VZV proteins is 23~ (Chee et al., 1989 ). An amino acid identity of 25~ was found between the MCP of HCMV and the VP5 of HSV-1 (Chee et al., 1989) . Recently, the sequence for the major capsid protein of human herpesvirus 6 (HHV-6) was compared with the MCP of HCMV and showed an amino acid identity of 43~o (Lawrence et al., 1990 ).
The present study describes the immunoreactivity of the cytomegalovirus MCP with HCMV antibody- H C M V (strain AD169) and HSV-1 (strain A N G ) virion proteins were subjected to electrophoresis in a 1 0~ polyacrylamide gel, transferred to nitrocellulose and assayed with the effluents of specific human antibodies to FS 1. Three sera reacted with both the H C M V MCP and the VP5 of HSV-1 as indicated by the arrows. More information about the h u m a n antisera is given in Table 1 . M T (M) markers as for Fig. 3 .
T a b l e l. Listing of HCMV-and HSV-l-positive human sera used in affinity chromatography and immunoblotting
Lab. no. positive human sera, its prokaryotic expression and the immunogenicity of the recombinant proteins. Furthermore we have tried to define the specificity of anti-HCMV rabbit and mouse antibodies cross-reactive with the VP5 of HSV-1 in immunoblotting and immunofluorescence. We also provide evidence for the presence of cross-reactive antibodies in human serum samples as assessed by affinity chromatography and immunoblots.
HCMV
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First of all, a number of HCMV-positive human antisera were investigated for immunoreactivity with the viral MCP. About 30~ of these antisera recognized the viral MCP in immunoblotting. This is in good agreement with previous observations reporting a limited immunogenicity of the HCMV MCP (Jahn et al., 1987a (Fig. 1) . This leads to the conclusion that the immunodominant region is located within the N-terminal 227 amino acids of fusion protein FS 1. The fusion proteins were used for generating polyvalent antisera in rabbits. The rabbit antisera confirmed the observation above that the recombinant proteins did not share common epitopes. All rabbit antisera reacted only with the fusion protein applied for immunization. In contrast to the obviously limited antibody response of the MCP during natural infection in man, the recombinant proteins worked as efficient antigens in rabbits. Polyvalent HCMV rabbit antisera and a monoclonal MCP antibody were taken to investigate cross-reactivity with HSV-1. A variety of experimental approaches have suggested that the major capsid protein may play a role in cross-reactions between various members of the herpesvirus group (Ross et al., 1972; Honess et al., 1974) . Antigenic conservation has subsequently been detected between the closely related major capsid proteins of HSV-1 and HSV-2, between the MCPs of canine herpesvirus and pseudorabies virus, and between the major capsid proteins of HSV-1 and pseudorabies virus (Eberle & Courtney, 1981 ; Yeo et al., 1981 ; Manning et al., 1988) . In addition, Weiner & Gibson (1981) observed antigenic cross-reactions between the MCPs of simian cytomegalovirus and HCMV. In our study the rabbit antiserum SH 1, a polyvalent serum raised against the viral MCP of HCMV, and a monoclonal antibody directed against the HCMV fusion protein SH 1 detected the VP5 of HSV-1 in immunofluorescence and immunoblotting. Incubation of the MCP antibodies with HCMV-infected fibroblasts revealed a nuclear fluorescence at times late after infection. Yamauchi et al. (1985) previously reported on the intracellular transport of the HCMV MCP into the nucleus using electron microscopy and separation of nuclear fractions in protein gels. In some immunofluorescence experiments using HSV-1-infected cells incubated with HCMV MCP antibodies, we observed a distinct nuclear staining as has been described for VP5 by Bibor-Hardy et al. (1985) and for the MCP of EBV by Vroman et al. (1985) . In addition, a monoclonal antibody (IV. 26.1) raised against the VP5 of HSV-1 (strain ANG) was incubated with HCMV and HSV-2 (strain 333) viral proteins. This monoclonal antibody did not react with the MCP of HCMV or with the major capsid protein of HSV-2 suggesting that this antibody recognized a type-specific epitope. On the other hand, the monoclonal HCMV antibody 28-4 did not detect the major capsid protein of HSV-2 either.
To determine whether HCMV-and HSV-l-positive human antisera contain antibodies cross-reacting with the MCP and the VP5, antibodies were purified from individual antisera on CNBr-activated Sepharose columns. Balachandran et al. (1987) applied this method to obtain monospecific rabbit antisera for the investigation of antigenic cross-reactions among four human herpesviruses. We selected eight human antisera according to their reactivity with the MCP of HCMV and the VP5 of HSV-1 in immunoblots. MCP-specific antibodies were concentrated and purified on affinity chromatography columns containing HCMV fusion proteins. Application of the MCP fusion proteins allowed the conjugation of large amounts of antigen to affinity columns, leading to a high antibody binding capacity. Using this approach, three antibody effluents of human sera were obtained cross-reacting between the MCP of HCMV and the VP5 of HSV-1 in immunoblots. All three patient sera were HCMV IgM-positive in ELISA or high-titred in CFT (see Table 1 ). In contrast to the cross-reactive rabbit antiserum SH 1 and the cross-reactive monoclonal antibody 28-4, which were both reactive with fusion protein SH 1, we observed cross-reactivity only of those human antibodies specific to fusion protein FS 1. This could be due to the limited number of human antisera reactive with fusion protein SH 1, as the majority of human antisera recognize fusion protein FS 1. According to amino acid comparisons all parts of the HCMV MCP showed about the same degree of homology to the VP5. However, using the combination of affinity chromatography and immunoblot procedures we cannot comment on the presence of cross-reactive human antibodies directed against non-linear epitopes of the major capsid proteins of HCMV and HSV-1. Furthermore, methods applied in this study do not allow the discrimination between unidirectional and bidirectional cross-reactivity among both viruses.
In conclusion, we provide evidence for the existence of cross-reactive antibodies between the major capsid proteins of HCMV and HSV-1 that may reflect relevant immunological and biological properties of both proteins. In addition, the observed cross-reactivity may interfere with diagnostic procedures. Thus, the possibility of false positive results due to cross-reacting antibodies cannot be excluded.
